📰 Structural Proteins News
Structural Proteins News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Structural Proteins. Real-time updates on events, politics, business and more.
April 2, 2024
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The
December 9, 2022
/PRNewswire/ -- The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
December 9, 2022
/PRNewswire/ -- The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...
December 6, 2022
DUBLIN--(BUSINESS WIRE)--The "Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development, Biopharma Production, Research, Diagnostics), End User (Biotech, CROs) - Global Forecast to 2027" report has been added to ResearchAndM...
April 19, 2022
The Institute loses a scientist of high standing. Klaus Kühn (*1.5.1927 - † 8.4.2022), was one of the founding directors of the Max Planck Institute (MPI) of Biochemistry in Martinsried.
January 28, 2022
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic due to the high transmission and mortality rate of this virus. The world health and economic sectors have been severely affected by this deadly virus, exacerbated by the lack of sufficient efficient vaccines. The design of effective drug candidates and their rapid development is necessary to combat this virus. In this study, we selected 23 antimicrobial peptides from the literature and predicted thei...
December 2, 2021
Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities
December 2, 2021
Recombinant Proteins Market worth $1.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities
October 1, 2021
/PRNewswire/ -- According to the new market research report "Biosimilars Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab),...
March 8, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1 billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry academia collaborations, and the patent expiry of biologic products. Emerging markets in Asian ...